Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 mut AML in MRDneg remission after intensive induction.
Journal: HemaSphere
Published: February 02, 2025
Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA.
Journal: Experimental hematology
Published: February 04, 2021
Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 26, 2018
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2018
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 12, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026